The goal of this cluster Randomized Control Trial is to determine the effectiveness of Asthma Link, a school supervised asthma therapy program, compared with an educational asthma workbook, in improving asthma symptoms for children with poorly controlled asthma aged 5-14.
Asthma is an extremely common chronic disease in childhood with significant morbidity. The majority of asthma morbidity in children is due to medication non-adherence, and both morbidity and medication non-adherence disproportionately impact minoritized children. School-supervised asthma therapy ensures that children receive their preventive asthma medication daily at school and has shown efficacy in improving medication adherence and asthma health outcomes, particularly in low-income and racial/ethnic minority children. However, this strategy has not been widely adopted in practice to produce meaningful public health impact. To address this gap, the study team developed a new model, Asthma Link, which partners pediatric practices, schools, and families to deliver school-supervised asthma therapy. This intervention leverages established infrastructure and requires minimal resources to operate, enhancing sustainability in a real-world setting. The pilot trial of Asthma Link showed improved asthma symptoms when compared to an enhanced usual care condition, particularly among low-income, Black and Latino children, and demonstrated trial feasibility. Moreover, the research team has rigorously adapted this intervention for real-world use using input from diverse, multi-level community stakeholders. This 14 site cluster randomized controlled trial will determine the effectiveness of Asthma Link versus an enhanced usual care condition in improving asthma health outcomes in school-aged children with poorly controlled asthma. The investigators central hypothesis is that children in Asthma Link will have higher Asthma Control Test scores at 6 months compared with children in enhanced usual care; with maintained improvements at 12 months. The secondary hypothesis is that children in Asthma Link will have higher inhaled corticosteroid adherence and quality of life scores, and lower rates of asthma exacerbations, school absences and parental lost workdays compared with children in the enhanced usual care condition.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
350
Providers enroll patients to receive school-supervised asthma therapy and an asthma educational workbook
Providers enroll patients to receive an asthma educational workbook
University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States
RECRUITINGImproving Asthma Symptoms
Asthma Control Test to measure child's asthma control on a scale of 0-25. A score of 19 or less is considered poorly controlled asthma.
Time frame: Baseline, 6 months, 12 months
Improving Medication Adherence
Survey to measure medication adherence
Time frame: Baseline, 6 months, 12 months
Improving Healthcare Utilization
Survey questions to measure # of emergency room visits, # of hospital admissions, # of oral steroid courses due to asthma
Time frame: Baseline, 6 months, 12 months
Reducing Parental Lost Workdays
Survey to measure the number of days a parent has missed work
Time frame: Baseline, 6 months, 12 months
Reducing School Absences
Survey to measure the number of days a child has missed school
Time frame: Baseline, 6 months, 12 months
Improving Quality of Life
Survey to measure the quality of life of the child and parent
Time frame: Baseline, 6 months, 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.